Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?

To establish whether women over 65 years of age with newly diagnosed with breast cancer (BC) receive adjuvant chemotherapy less frequently than younger postmenopausal women and whether comorbidity influences this potential undertreatment.

Saved in:
Bibliographic Details
Main Authors: Wallwiener, Christian Wilhelm (Author) , Hartkopf, A. D. (Author) , Grabe, E. (Author) , Wallwiener, Markus (Author) , Taran, F.-A. (Author) , Fehm, T. (Author) , Brucker, S. Y. (Author) , Krämer, B. (Author)
Format: Article (Journal)
Language:English
Published: 27 June 2016
In: Journal of cancer research and clinical oncology
Year: 2016, Volume: 142, Issue: 8, Pages: 1847-1853
ISSN:1432-1335
DOI:10.1007/s00432-016-2194-4
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00432-016-2194-4
Get full text
Author Notes:C. W. Wallwiener, A. D. Hartkopf, E. Grabe, M. Wallwiener, F.-A. Taran, T. Fehm, S. Y. Brucker, B. Krämer
Description
Summary:To establish whether women over 65 years of age with newly diagnosed with breast cancer (BC) receive adjuvant chemotherapy less frequently than younger postmenopausal women and whether comorbidity influences this potential undertreatment.
Item Description:Gesehen am 05.06.2020
Physical Description:Online Resource
ISSN:1432-1335
DOI:10.1007/s00432-016-2194-4